Video: Alex Kotlowitz on Hoop Dreams and Kartemquin

Kartemquin is proud to release the video of noted author and journalist Alex Kotlowitz (There Are No Children Here) delivering the keynote speech from our recent 15th anniversary celebration of Hoop Dreams. Discussing the impact of the film, his current film collaboration with director Steve James (The Interrupters), and the importance of Kartemquin's ongoing legacy of social issue documentary filmmaking, Kotlowitz states: Continued

Sage Foundation awards On Beauty $45,000 production grant

Kartemquin is thrilled to announce that On Beauty -- the story of how a former fashion photographer is redefining the way we see and experience beauty -- received a grant for $45,000 from Sage Foundation to support production on the film. Thanks to this generous donation, producer/director Joanna Rudnick and a Kartemquin film crew will travel to East Africa with photographer Rick Guidotti and his organization Positive Exposure ( to document the courageous children living with Albinism in that region in 2010. To support On Beauty, click here. Continued

Gordon Quinn testifies at FCC Hearing on Broadband rights

Kartemquin Films Co-Founder and Artistic Director Gordon Quinn is testifying in Chicago this afternoon at an FCC public Field Hearing focusing on how broadband technology can help small businesses spur growth and reach new markets. The hearing will take place at the University of Chicago's Gleacher Center at 450 North Cityfront Plaza Drive. Gordon will be specifically addressing the value of broadband for distribution of media, and the challenges for public media as broadband adoption increases. Other speakers include: Continued

In the Family at the heart of gene patenting debate

"Should human genes ever be the subject of patent protection?" - Wall St. Journal Media coverage about the issue of gene patenting has increased in recent weeks relating to a landmark legal case on behalf of several patients who carry the BRCA1 and BRCA1 genes, filed against the United States Patent and Trademark Office and Myriad Genetics. Last week the Wall. St. Journal had an article about the case, and the issue of gene patenting was also the focus on NPR Radio's Science Friday. Continued